Pharma Industry News

Report reveals murky picture of clinical trial diversity gains

3 years ago
by David Miller
951 Views

Data discrepancies between study phases and indications could provide clues about why some trials have better racial and ethnic diversity than others.

Data discrepancies between study phases and indications could provide clues about why some trials have better racial and ethnic diversity than others.

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts
[mwai_chat window="true" fullscreen="true"]